In 2004, Gilead Sciences decided to stop pursuing a new H.I.V. drug. The public explanation was that it wasn’t sufficiently different from an existing treatment to warrant further development.In private, […]
Acquired Immune Deficiency Syndrome
Trending topics and news from the Acquired Immune Deficiency Syndrome category
Back to news homeGilead Wins Key Patent Rights Suit Over PrEP Drugs for Preventing HIV
A federal jury in Delaware on Tuesday found that the federal government did not have an ownership claim to lucrative drugs to prevent H.I.V. that are sold by the pharmaceutical […]